Laser Helmet for Parkinson’s Disease | NeuroThera Study
Laser Helmet for Parkinson’s Disease: NeuroThera’s Non-Invasive Therapy
NeuroThera is developing a laser helmet for Parkinson’s disease that could transform how we treat neurological conditions. This non-invasive method uses infrared light to stimulate brain activity without the need for medication or surgery.
Laser Helmet Study Shows Promising Results
In collaboration with the University of Delaware, NeuroThera conducted a pilot study where participants wore the helmet for 18 sessions over six weeks. The results showed improved blood flow, cognitive performance, and brain stimulation.
For example, one participant noted improvements in memory, task management, and multitasking—benefits that occurred even when off medication. This indicates the potential of laser helmets for Parkinson’s disease as a supportive or alternative therapy.
Moreover, the double-blind, placebo-controlled study strengthens the evidence for the laser helmet’s efficacy. Thus, researchers are hopeful about broader clinical success.
Why the Laser Helmet for Parkinson’s Disease Matters
- Non-invasive: No surgery or pharmaceutical drugs involved.
- Multi-purpose potential: May help in conditions like Alzheimer’s, depression, and traumatic brain injuries.
- Scientifically backed: Uses cognitive and motor assessments to measure effects.
Next Steps in Laser Helmet Development
NeuroThera aims to begin Phase II trials soon. If results continue to be positive, this laser helmet for Parkinson’s disease may be widely used as a safe and accessible option.
You can learn more on NeuroThera’s official website. Additionally, read the full university report on the University of Delaware news portal.
Want to know more about Parkinson’s symptoms? Visit our Parkinson’s Disease Overview page.
© 2025 P7 Neuro News. All rights reserved. This article is based on publicly available clinical trial information and university publications.
Laser Helmet for Parkinson’s Disease: NeuroThera’s Non-Invasive Therapy
NeuroThera is developing a laser helmet for Parkinson’s disease that could transform how we treat neurological conditions. This non-invasive method uses infrared light to stimulate brain activity without the need for medication or surgery.
Laser Helmet Study Shows Promising Results
In collaboration with the University of Delaware, NeuroThera conducted a pilot study where participants wore the helmet for 18 sessions over six weeks. The results showed improved blood flow, cognitive performance, and brain stimulation.
For example, one participant noted improvements in memory, task management, and multitasking—benefits that occurred even when off medication. This indicates the potential of laser helmets for Parkinson’s disease as a supportive or alternative therapy.
Moreover, the double-blind, placebo-controlled study strengthens the evidence for the laser helmet’s efficacy. Thus, researchers are hopeful about broader clinical success.
Why the Laser Helmet for Parkinson’s Disease Matters
- Non-invasive: No surgery or pharmaceutical drugs involved.
- Multi-purpose potential: May help in conditions like Alzheimer’s, depression, and traumatic brain injuries.
- Scientifically backed: Uses cognitive and motor assessments to measure effects.
Next Steps in Laser Helmet Development
NeuroThera aims to begin Phase II trials soon. If results continue to be positive, this laser helmet for Parkinson’s disease may be widely used as a safe and accessible option.
You can learn more on NeuroThera’s official website. Additionally, read the full university report on the University of Delaware news portal.
Want to know more about Parkinson’s symptoms? Visit our Parkinson’s Disease Overview page.
